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ABSTRACT
Background: Protein induces an increase in insulin concentra-
tions when ingested in combination with carbohydrate. Increases
in plasma insulin concentrations have been observed after the
infusion of free amino acids. However, the insulinotropic prop-
erties of different amino acids or protein (hydrolysates) when co-
ingested with carbohydrate have not been investigated.
Objective: The aim of this study was to define an amino acid
and protein (hydrolysate) mixture with a maximal insulinotropic
effect when co-ingested with carbohydrate.
Design: Eight healthy, nonobese male subjects visited our labo-
ratory, after an overnight fast, on 10 occasions on which differ-
ent beverage compositions were tested for 2 h. During those
trials the subjects ingested 0.8 g · kg21 · h21 carbohydrate and
0.4 g ·kg21 ·h21 of an amino acid and protein (hydrolysate) mixture.
Results: A strong initial increase in plasma glucose and insulin
concentrations was observed in all trials, after which large dif-
ferences in insulin response between drinks became apparent.
After we expressed the insulin response as area under the curve
during the second hour, ingestion of the drinks containing free
leucine, phenylalanine, and arginine and the drinks with free
leucine, phenylalanine, and wheat protein hydrolysate were fol-
lowed by the largest insulin response (101% and 103% greater,
respectively, than with the carbohydrate-only drink; P < 0.05).
Conclusions: Insulin responses are positively correlated with
plasma leucine, phenylalanine, and tyrosine concentrations. A
mixture of wheat protein hydrolysate, free leucine, phenylala-
nine, and carbohydrate can be applied as a nutritional supple-
ment to strongly elevate insulin concentrations. Am J Clin
Nutr 2000;72:96–105.
KEY WORDS Insulin secretion, amino acid supplementation,
protein hydrolysates, leucine, arginine, phenylalanine, glutamine,
healthy men
INTRODUCTION
The synergistically stimulating effect of the combined intake
of carbohydrates and protein on plasma insulin concentrations
was described for the first time in the 1960s (1, 2) and was con-
firmed later by Nuttall et al (3, 4). The insulinotropic effect of
intravenous amino acid administration was also studied in the
1960s by Floyd et al (5–10). Infusion of several amino acids led
to significant increases in plasma insulin. A mixture of 10 amino
acids and equimolar quantities of arginine or leucine only
were found to be the most potentiating. Floyd et al also
observed a synergistic effect when glucose was administered
intravenously with these amino acids. After different combina-
tions of amino acids were investigated, the combined intravenous
administration of arginine-leucine and arginine-phenylalanine,
together with glucose, resulted in the largest increase in
plasma insulin concentrations. Several in vitro studies using
incubated b-cells of the pancreas showed strong insulinotropic
effects of arginine, leucine, phenylalanine, and leucine in
combination with glutamine (11–20).
A strong elevation of plasma insulin concentrations after the
ingestion of carbohydrates in combination with a highly insulino-
tropic amino acid and protein mixture could be of experimental as
well as practical importance. For example, in metabolic research
such a mixture could be used as a tool to elevate insulin concen-
trations in vivo without intravenous insulin administration. In
patients with type 2 diabetes, the mixture could be used as a
means of evaluating the responsiveness of the pancreas. Although
more research should be performed, such a mixture could possi-
bly also be of use as a nutritional insulinotropic supplement
during the early stages of declining insulin sensitivity in type 2
diabetes, potentially postponing patients’ dependency on exoge-
nous insulin administration. In sports nutrition, the addition of an
insulinotropic amino acid and protein mixture to carbohydrate
drinks could represent a means of increasing postexercise glyco-
gen synthesis rates, as was shown by Zawadzki et al (21), and was
investigated by us in another study (22).
Currently there is no literature available that provides clear
insight into the type, combination, and quantity of free amino
acids or protein sources that should be taken orally in combination
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with carbohydrates to maximize the in vivo insulin response. The
aim of this study was to define an amino acid and protein
(hydrolysate) mixture with an optimal insulinotropic effect when
added to a carbohydrate drink. A total of 10 drinks were tested in
healthy subjects after an overnight fast to investigate the
insulinotropic potential of several free amino acids, protein
hydrolysates, and an intact protein. Because it was our aim also
to investigate the efficiency of such an insulinotropic mixture in
increasing postexercise muscle glycogen synthesis (22), similar
amounts of carbohydrate and of the amino acid or protein
(hydrolysate) mixture were administered, as used previously by
Zawadzki et al (21). The choice of the free amino acid composi-
tions tested in this study was based mainly on the outcome of
studies by Floyd et al (5–10).
SUBJECTS AND METHODS
Subjects
Eight healthy, nonobese male subjects [x– – SE age: 21 – 0.4 y;
weight: 73.9 – 2.2 kg; height: 186 – 2 cm; BMI (in kg/m2):
21.4 – 0.7] participated in this study. All subjects were informed
about the nature and risks of the experimental procedures before
their informed consent was obtained. The study was approved by
the Ethical Committee of the Academic Hospital Maastricht.
Experimental trials
Each subject participated in 10 trials, separated by ‡ 3 d, in
which 10 different beverages were tested. All studies lasted 2 h,
during which the subjects were seated and remained inactive.
In the initial part of the study, test drinks 1 to 8 (see below)
were tested. Beverages 9 and 10 were composed and tested
within 3 wk after analysis of the acquired data on test drinks
1–8. In both parts of the study, beverages were provided in a
random, double-blind fashion. All drinks were vanilla flavored
so that the taste would be similar in all trials. The subjects were
instructed to refrain from any sort of heavy physical labor and
to keep their diets as constant as possible the day before the tri-
als. The subjects had to fast for 12 h before reporting to the lab-
oratory; during that period, the subjects were allowed to drink
water or tea (without sugar).
Protocol
The subjects reported to the laboratory at 0830 after an
overnight fast. A polytetrafluoroethylene catheter (Quick-Cath;
Baxter Healthcare SA, Swinford, Ireland) was inserted into an
antecubital vein and a resting blood sample was drawn at time
zero. Immediately thereafter, the subjects drank an initial bolus
(3.5 mL/kg) of a given test drink. Repeated boluses (3.5 mL/kg)
were taken every 30 min for 90 min. Blood samples were drawn
at 15-min intervals for measurement of plasma glucose and
insulin concentrations. Amino acid concentrations were meas-
ured in blood samples taken at 0, 60, and 120 min.
Beverages
At 0, 30, 60, and 90 min, the subjects received a beverage vol-
ume of 3.5 mL/kg to ensure a given dose of 0.8 g carbohy-
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TABLE 1
Composition of the 10 test drinks
Test drink 1 2 3 4 5 6 7 8 9 10
g/L
Arginine — 57.1 19.0 14.3 — — — — — 9.50
Glutamine — — — 14.3 — — — — — —
Leucine — — 19.0 14.3 — — — — 14.3 9.50
Phenylalanine — — 19.0 14.3 — — — — 14.3 9.50
Whey hydrolysate — — — — 57.1 — — — — —
Pea hydrolysate — — — — — 57.1 — — — —
Wheat hydrolysate — — — — — — 57.1 — 28.6 28.6
Casein (milk protein) — — — — — — — 57.1 — —
Glucose 57.1 57.1 57.1 57.1 57.1 57.1 57.1 57.1 57.1 57.1
Maltodextrin 57.1 57.1 57.1 57.1 57.1 57.1 57.1 57.1 57.1 57.1
Sodium saccharinate 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20
Citric acid 1.80 1.80 1.80 1.80 1.80 1.80 1.801 1.80 1.80 1.80
Cream vanilla flavor 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00
TABLE 2
Amino acid composition of hydrolysates and intact casein protein
Amino acid Whey Pea Wheat Casein
% by wt
L-Alanine 4.7 3.8 1.8 3.1
L-Cysteine 1.2 0.4 0.9 0.4
L-Aspartate 5.4 4.4 0.2 3.7
L-Glutamate 9.1 7.4 3.2 11.2
L-Phenylalanine 2.4 3.2 4.8 5.4
L-Glycine 1.6 2.8 2.8 1.9
L-Histidine 1.6 1.7 1.6 3.2
L-Isoleucine 5.1 2.4 2.6 5.8
L-Lysine 8.4 5.9 — 8.3
L-Leucine 8.7 5.1 5.6 10.1
L-Methionine 1.3 0.6 1.1 3.0
L-Asparagine 4.4 3.8 1.9 3.7
L-Proline 5.9 2.8 12.3 10.5
L-Glutamine 7.4 6.6 29.0 11.2
L-Arginine 2.0 6.9 2.2 3.8
L-Serine 5.1 4.0 4.4 6.3
L-Threonine 6.6 2.8 2.0 4.6
L-Valine 4.5 2.7 3.0 7.4
L-Tryptophan 1.2 — — 1.4
L-Tyrosine 2.3 2.6 2.5 5.8
drate/kg (50% as glucose and 50% as maltodextrin) and 0.4 g/kg
of an amino acid and protein (hydrolysate) mixture every hour.
The compositions of all test drinks are listed in Table 1. Glucose
and maltodextrin were obtained from AVEBE (Veendam, Nether-
lands), crystalline amino acids were obtained from BUFA (Uit-
geest, Netherlands), protein hydrolysates were prepared by
Quest (Naarden, Netherlands), and sodium-casein was obtained
from DMV (Veghel, Netherlands). Amino acid profiles of the
protein hydrolysates and the intact protein tested were provided
by the manufacturers and are listed in Table 2. All test drinks
were uniformly flavored by adding 0.8 g sodium-saccharinate
solution (25%, by wt), 3.6 g citric acid solution (50%, by wt),
and 5 g of a cream vanilla flavor (Quest) for each 1-L drink.
Analysis
Blood (4 mL) was collected in EDTA-containing tubes and
centrifuged at 1000 3 g and 4 8C for 5 min. Aliquots of plasma
were frozen immediately in liquid nitrogen and stored at 240 8C.
Glucose (Uni Kit III, 07367204; La Roche, Basel, Switzerland)
was analyzed with the Cobas Fara semiautomatic analyzer
(Roche, Basel, Switzerland). Insulin was analyzed by radioim-
munoassay (Insulin RIA 100 kit; Pharmacia, Uppsala, Sweden).
Plasma (200 mL) for amino acid analysis was deproteinized on
ice with 50% (wt:vol) 5-sulfosalicylic acid and mixed, and the
clear supernate obtained after centrifugation was stored at 280 8C
until analyzed. Amino acids were analyzed on an automated
dedicated amino acid analyzer (LC5001; Biotronik, München,
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FIGURE 2. Mean ( – SE) total 2-h plasma glucose responses (area
under the curve; AUC) to each test drink. n = 8. *Significantly different
from drink 3, P < 0.05. For the exact compositions of the different
drinks, see Tables 1 and 2.
FIGURE 3. Mean ( – SE) 2nd-h plasma glucose response (area under
the curve; AUC) to each test drink. n = 8. For the exact compositions of
the different drinks, see Tables 1 and 2.
FIGURE 1. Mean ( – SE) plasma glucose concentrations after ingestion of the control drink and drinks containing free amino acids (A), the control
drink and drinks containing hydrolysates and an intact protein (B), and the control drink and drinks containing mixtures of hydrolysate and free amino
acids (C). n = 8. For the exact compositions of the different drinks, see Tables 1 and 2.
Germany) with use of a cationic exchange resin (type BTC2710;
Biotronik), a gradient of lithiumcitrate elution buffers, and post-
column derivatization with ninhydrin, all according to working
recipes of the suppliers. The same procedures were performed to
determine the amino acid composition of the protein (hydro-
lysates), except that a different amino acid analyzer was used
(Pharmacia LKB Biotechnology, Roosendaal, Netherlands).
Calibration curves of the amino acids were obtained by using
commercial amino acid mixtures. Norvaline was used as internal
standard and added to all plasma samples before deproteinization.
Questionnaires
After ingesting the beverage at 60 min and at the completion of
each trial, the subjects were asked to fill out a questionnaire
that contained questions about gastrointestinal discomfort and
other complaints at that time. The presence of nausea, bloated
feeling, belching, gastrointestinal cramping, vomiting, diarrhea,
urge to defecate, urge to urinate, headache, and dizziness was
scored on a 10-point scale (1, absent; 10, strongly present).
Statistics
All data are expressed as means – SEMs (n = 8). The plasma
glucose, insulin, and amino acid responses were calculated as
area under the curve above baseline value (at 0 min). Statistical
analysis of the data was performed by using a 2-factor (treat-
ment and subjects) repeated-measures analysis of variance
(ANOVA). Differences between drinks were tested for signifi-
cance by using Tukey’s post hoc test. In addition, simple regres-
sion analysis was performed to calculate correlations between
the insulin response and the different plasma amino acid
responses. Significance was set at P < 0.05.
RESULTS
Ingestion of all drinks resulted in an increase in plasma glucose
concentrations during the first 30 min, after which concentrations
decreased and stabilized during the second hour (Figure 1). After
the glucose response was expressed as area under the curve (above
baseline) during the entire 2-h trial, significant differences were
found between drinks 3 and 7 (Figure 2: arginine, leucine, and
phenylalanine and wheat protein hydrolysate, respectively). When
we focused on the second hour, we found no significant differ-
ences in glucose response between the trials (Figure 3).
From baseline onward, plasma insulin concentrations strongly
increased for the first 30–45 min. After this strong initial
increase, insulin concentrations reached a plateau in trials 1 and
2, ie, the control (carbohydrate only) and arginine drinks, respec-
tively (Figure 4A). Plasma insulin concentrations after the
ingestion of drinks 5, 6, 7, and 8 increased more and leveled off
between 45 and 60 min (Figure 4B). Insulin concentrations after
ingestion of free amino acid–containing drinks 3, 4, 9, and 10
continued to increase during the last 30 min (Figure 4, A and C).
After we expressed the insulin response as the area under the
curve (above baseline) during the entire 2-h period, we found
significant differences between drink 2 and drinks 3, 4, 7, and 9
(126%, 124%, 122%, and 105% greater than with drink 2,
respectively) (Figure 5). Compared with the control trial, mean
differences as large as 57%, 55%, 54%, and 42%, respectively
were found (not significant). Because of the large intersubject
variability during the first 45–60 min, caused by differences in
gastric emptying and absorption rates, insulin responses were
calculated over the second hour. During the second hour plasma
insulin responses measured during the administration of drinks 3
and 9 were 2-fold higher than with the carbohydrate-only drink
(101% and 103% greater, respectively) (Figure 6). Insulin
responses after ingestion of drinks 3, 4, 7, and 9 were also signi-
ficantly higher than after ingestion of the arginine drink (Figure
6). Insulin concentrations at 120 min were substantially higher
after ingestion of drinks 3 and 9 than after ingestion of the con-
trol drink (122% and 106% greater, respectively).
Mean plasma amino acid concentrations at baseline, 60 min,
and 120 min are reported in Tables 3, 4, and 5. Plasma amino
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FIGURE 4. Mean ( – SE) plasma insulin concentrations after ingestion of the control drink and drinks containing free amino acids (A), the control
drink and drinks containing hydrolysates and an intact protein (B), or the control drink and drinks containing mixtures of hydrolysate and free amino
acids. n = 8. For the exact compositions of the different drinks, see Tables 1 and 2. To convert from pmol/L to mU/L, divide by 7.25.
acid responses were calculated as area under the curve above
baseline values. A complete overview of the plasma amino acid
responses and the significant differences between the ingestion
of the various mixtures is provided in Table 6. Only the findings
most relevant to the aim of this study are discussed below. Plasma
leucine, phenylalanine, and arginine concentrations increased
significantly more after ingestion of drink 3 than after ingestion
of all other drinks and in parallel showed one of the highest
insulin responses. Ingestion of the other free amino acid–con-
taining drinks (4, 9, and 10) also resulted in significantly higher
plasma leucine and phenylalanine responses than did ingestion
of the other drinks (1, 2, 5, 6, 7, and 8). Although the amount of
free arginine administered in drink 2 was substantially larger
than that provided in drinks 3, 4, and 10, the increase in plasma
arginine concentrations was significantly lower after ingestion of
drink 2 than after ingestion of drinks 3, 4, and 10. Addition of the
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FIGURE 5. Mean ( – SE) total 2-h plasma insulin response (area
under the curve; AUC) to each test drink. n = 8. *Significantly different
from drink 2, P < 0.05. For the exact compositions of the different
drinks, see Tables 1 and 2.
FIGURE 6. Mean ( – SE) 2nd-h plasma insulin response (area under
the curve; AUC) to each test drink. n = 8. #Significantly different from
drink 1 (control), P < 0.05. *Significantly different from drink 2, P <
0.05. For the exact compositions of the different drinks, see Tables 1 and 2.
TABLE 3
Plasma amino acid concentrations after ingestion of drinks 1–4 containing amino acids and carbohydrate1
Drink 1 (control) Drink 22 Drink 33 Drink 44
0 min 60 min 120 min 0 min 60 min 120 min 0 min 60 min 120 min 0 min 60 min 120 min
µmol/L
Threonine 102 – 7 90 – 6 82 – 6 108 – 2 99 – 6 87 – 3 103 – 5 85 – 6 64 – 4 93 – 5 77 – 5 61 – 4
Serine 91 – 5 81 – 6 70 – 5 98 – 6 88 – 7 75 – 5 90 – 8 73 – 7 55 – 6 87 – 7 72 – 6 57 – 5
Asparagine 52 – 4 46 – 4 42 – 3 49 – 2 44 – 4 38 – 2 50 – 3 40 – 3 31 – 2 48 – 3 39 – 3 31 – 3
Glutamate 78 – 10 83 – 9 76 – 10 124 – 11 111 – 9 127 – 5 110 – 16 85 – 10 73 – 10 115 – 9 76 – 8 80 – 8
Glutamine 667 – 32 624 – 21 600 – 28 631 – 29 597 – 32 566 – 11 578 – 25 601 – 31 556 – 14 559 – 28 642 – 29 616 – 30
Proline 147 – 13 134 – 14 128 – 15 162 – 18 164 – 25 154 – 19 174 – 21 144 – 18 124 – 18 160 – 21 128 – 20 112 – 19
Glycine 217 – 16 201 – 15 192 – 14 228 – 11 203 – 9 198 – 11 221 – 12 175 – 10 142 – 8 218 – 15 174 – 14 148 – 15
Alanine 291 – 25 302 – 21 306 – 18 334 – 34 314 – 32 350 – 20 324 – 31 297 – 23 271 – 17 296 – 24 296 – 20 284 – 18
Citrulline 28 – 2 16 – 1 12 – 1 30 – 1 26 – 2 20 – 2 28 – 2 30 – 2 29 – 2 28 – 1 33 – 2 40 – 3
a-Aminobutyrate 21 – 2 20 – 2 19 – 1 21 – 3 20 – 3 18 – 3 18 – 3 17 – 3 15 – 1 21 – 2 19 – 2 16 – 1
Valine 224 – 7 195 – 7 169 – 5 247 – 5 219 – 6 185 – 2 236 – 9 194 – 7 118 – 5 218 – 6 177 – 6 111 – 5
Methionine 24 – 1 20 – 1 16 – 1 23 – 1 20 – 1 15 – 1 22 – 1 19 – 1 10 – 0 21 – 1 16 – 1 9 – 1
Isoleucine 64 – 1 48 – 2 33 – 2 67 – 4 53 – 3 30 – 2 62 – 3 40 – 2 11 – 1 63 – 2 41 – 3 11 – 1
Leucine 121 – 4 90 – 6 67 – 4 131 – 3 108 – 6 73 – 3 116 – 5 568 – 48 804 – 32 117 – 4 502 – 37 584 – 67
Tyrosine 58 – 3 51 – 4 44 – 3 61 – 3 52 – 4 42 – 3 55 – 3 99 – 8 131 – 12 50 – 2 96 – 7 167 – 44
Phenylalanine 57 – 3 47 – 4 41 – 3 67 – 2 57 – 3 49 – 2 61 – 2 407 – 32 681 – 22 60 – 2 328 – 25 473 – 69
Tryptophan 44 – 3 39 – 3 33 – 3 45 – 2 43 – 3 37 – 2 40 – 2 34 – 2 23 – 2 36 – 2 30 – 1 37 – 17
Ornithine 47 – 3 42 – 5 36 – 3 53 – 3 87 – 8 163 – 15 54 – 5 143 – 11 260 – 24 50 – 6 125 – 11 197 – 21
Lysine 155 – 9 143 – 10 133 – 8 168 – 6 164 – 12 153 – 9 161 – 7 181 – 11 158 – 8 143 – 7 149 – 8 124 – 15
Histidine 73 – 2 67 – 1 63 – 2 79 – 3 72 – 4 65 – 3 72 – 2 62 – 3 47 – 2 70 – 2 61 – 3 52 – 2
Arginine 76 – 5 66 – 4 58 – 4 83 – 2 164 – 8 286 – 19 79 – 3 371 – 25 538 – 29 75 – 3 299 – 22 410 – 24
1 x– – SEM; n = 8. For compositions of drinks 1–4, see Tables 1 and 2.
2 Arginine.
3 Leucine, phenylalanine, and arginine.
4 Leucine, phenylalinine, arginine, and glutamine.
free amino acids to a wheat protein hydrolysate in trials 9 and 10
clearly resulted in significantly higher plasma leucine and
phenylalanine responses than did ingestion of the protein
(hydrolysates) in drinks 5, 6, 7, and 8. In general, the ingestion
of the intact protein resulted in less marked increases in various
plasma amino acid concentrations within the 2-h period than did
the ingestion of the protein hydrolysates. More detailed informa-
tion is provided in Tables 3–6.
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TABLE 4
Plasma amino acid concentrations after ingestion of drinks 5–8 containing protein (hydrolysate) and carbohydrate1
5 (whey) 6 (pea) 7 (wheat) 8 (casein)
0 min 60 min 120 min 0 min 60 min 120 min 0 min 60 min 120 min 0 min 60 min 120 min
µmol/L
Threonine 118 – 7 217 – 12 258 – 16 113 – 6 166 – 9 185 – 8 109 – 7 138 – 12 136 – 12 113 – 6 126 – 6 125 – 6
Serine 101 – 7 150 – 11 155 – 13 101 – 8 141 – 9 153 – 9 98 – 7 134 – 8 136 – 12 98 – 10 109 – 11 102 – 10
Asparagine 46 – 3 81 – 6 91 – 7 54 – 4 98 – 8 115 – 8 52 – 2 62 – 4 58 – 4 50 – 2 57 – 3 57 – 4
Glutamate 56 – 5 62 – 5 55 – 4 63 – 9 60 – 9 69 – 10 104 – 10 86 – 8 72 – 11 49 – 11 42 – 6 43 – 8
Glutamine 756 – 25 815 – 29 816 – 36 663 – 25 725 – 30 727 – 32 628 – 23 754 – 21 769 – 22 721 – 29 722 – 23 700 – 27
Proline 174 – 21 265 – 24 306 – 25 173 – 20 226 – 25 252 – 22 181 – 20 327 – 24 393 – 31 175 – 19 220 – 23 245 – 20
Glycine 244 – 16 239 – 14 254 – 20 238 – 8 285 – 12 307 – 14 231 – 11 260 – 14 273 – 16 237 – 14 229 – 14 224 – 15
Alanine 305 – 25 462 – 17 489 – 14 326 – 30 457 – 26 488 – 22 317 – 19 425 – 25 438 – 17 353 – 30 382 – 19 396 – 14
Citrulline 34 – 2 30 – 2 33 – 2 32 – 2 27 – 2 30 – 2 32 – 2 37 – 3 42 – 4 31 – 2 26 – 2 25 – 2
a-Aminobutyrate 30 – 3 34 – 5 36 – 4 18 – 2 19 – 2 18 – 2 19 – 2 21 – 2 19 – 2 17 – 2 17 – 2 16 – 2
Valine 254 – 10 366 – 11 403 – 8 241 – 3 312 – 7 344 – 7 243 – 6 293 – 8 294 – 8 248 – 8 268 – 8 262 – 6
Methionine 25 – 1 40 – 1 47 – 2 24 – 1 23 – 1 18 – 1 24 – 1 31 – 1 30 – 1 24 – 1 27 – 1 27 – 1
Isoleucine 69 – 4 155 – 5 185 – 7 63 – 2 107 – 4 121 – 4 70 – 2 98 – 3 95 – 5 72 – 3 81 – 3 79 – 3
Leucine 131 – 5 253 – 6 294 – 8 122 – 3 191 – 6 213 – 7 125 – 4 181 – 7 188 – 9 123 – 4 134 – 4 127 – 4
Tyrosine 59 – 4 81 – 4 90 – 5 57 – 2 82 – 4 98 – 5 58 – 4 81 – 5 93 – 6 55 – 2 61 – 3 62 – 3
Phenylalanine 64 – 3 80 – 3 81 – 2 59 – 2 82 – 3 93 – 2 60 – 3 85 – 2 97 – 3 60 – 2 66 – 2 66 – 2
Tryptophan 50 – 3 71 – 4 76 – 4 52 – 2 49 – 2 47 – 3 46 – 3 50 – 3 48 – 3 48 – 2 50 – 2 45 – 3
Ornithine 55 – 5 72 – 5 77 – 5 56 – 5 89 – 7 108 – 7 54 – 4 71 – 4 79 – 6 59 – 8 63 – 7 62 – 7
Lysine 178 – 10 323 – 10 374 – 10 175 – 6 299 – 12 348 – 12 171 – 8 174 – 12 159 – 10 166 – 9 192 – 8 200 – 8
Histidine 80 – 3 94 – 4 93 – 3 78 – 4 93 – 5 94 – 4 80 – 3 96 – 3 98 – 3 77 – 4 81 – 5 81 – 4
Arginine 83 – 5 107 – 4 113 – 4 82 – 4 163 – 11 196 – 13 82 – 4 103 – 5 107 – 6 83 – 3 86 – 3 83 – 4
1 x– – SEM; n = 8. For composition of drinks 5–8, see Tables 1 and 2.
TABLE 5
Plasma amino acid concentrations after ingestion of drinks 9 and 10 containing amino acid or protein hydrolysate and carbohydrate1
9 (leu/phe and wheat) 10 (leu/phe/arg and wheat)
0 min 60 min 120 min 0 min 60 min 120 min
µmol/L
Threonine 104 – 6 102 – 6 87 – 6 107 – 6 111 – 8 99 – 8
Serine 96 – 8 99 – 10 84 – 9 99 – 8 103 – 9 89 – 9
Asparagine 52 – 2 47 – 2 39 – 3 53 – 6 47 – 3 39 – 3
Glutamate 71 – 11 62 – 4 68 – 7 56 – 8 48 – 4 42 – 5
Glutamine 673 – 12 702 – 12 686 – 29 702 – 27 750 – 26 740 – 18
Proline 174 – 22 207 – 27 216 – 21 193 – 32 250 – 32 257 – 31
Glycine 239 – 13 217 – 12 197 – 13 232 – 11 216 – 10 203 – 13
Alanine 338 – 21 346 – 24 337 – 20 316 – 24 362 – 18 369 – 15
Citrulline 33 – 2 37 – 3 43 – 3 33 – 2 41 – 3 49 – 3
a-Aminobutyrate 15 – 1 14 – 1 11 – 1 18 – 2 17 – 2 14 – 2
Valine 241 – 7 234 – 5 180 – 6 247 – 10 245 – 8 188 – 7
Methionine 22 – 1 21 – 1 16 – 1 23 – 1 25 – 1 19 – 1
Isoleucine 68 – 2 65 – 2 38 – 2 68 – 4 70 – 4 39 – 2
Leucine 122 – 4 518 – 37 654 – 43 122 – 4 455 – 21 542 – 20
Tyrosine 54 – 3 112 – 9 141 – 10 53 – 2 114 – 8 150 – 13
Phenylalanine 61 – 3 342 – 34 526 – 37 60 – 1 270 – 19 411 – 19
Tryptophan 46 – 2 42 – 2 32 – 2 43 – 2 43 – 2 35 – 2
Ornithine 57 – 5 65 – 6 70 – 6 58 – 5 123 – 8 175 – 14
Lysine 169 – 11 164 – 12 147 – 14 160 – 7 177 – 9 155 – 11
Histidine 77 – 2 76 – 2 69 – 2 78 – 4 79 – 4 70 – 3
Arginine 83 – 3 94 – 4 95 – 5 80 – 3 289 – 15 370 – 20
1 x– – SEM; n = 8. Leu, leucine; phe, phenylalanine; arg, arginine. For composition of drinks 9–10, see Tables 1 and 2.
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Strong positive correlations were found between insulin
responses and increases in plasma leucine (P < 0.003),
phenylalanine (P < 0.02), tyrosine (P < 0.0001), and citrulline
(P < 0.0023). A significant negative correlation was observed
between insulin responses and plasma glutamate (P < 0.02)
concentrations.
The data derived from the questionnaires were analyzed, and
significant differences between drinks are indicated in Table 7.
Gastrointestinal problems were found after administration of the
arginine drink (2). Subjects scored higher for presence of urge to
defecate and diarrhea (3.1 and 3.4, respectively) after ingestion of
drink 2 than after ingestion of all other drinks (1.2 and 1.0,
respectively). Eventually, all subjects experienced severe diarrhea
for several hours during and after ingestion of test drink 2 (0.4 g
arginine kg body wt21 ·h21). This was not observed in trials 3 and
4, in which dosages of 0.13 and 0.10 g arginine ·kg body
wt21 · h21, respectively, were ingested. Furthermore, significantly
higher scores for the presence of headache and bloated feeling
were reported after ingestion of the free amino acids in drink 4
(1.6 and 3.3, respectively) than after ingestion of several other
test drinks (mean overall score: 1.1 and 1.7, respectively). In
addition, a significantly higher score for belching was found after
ingestion of the free amino acids in drink 3 (score: 3.4) than after
ingestion of several other test drinks (mean overall score: 1.8).
These symptoms were absent in the trials that combined those
free amino acids with a wheat protein hydrolysate (Table 7).
DISCUSSION
The results of this study indicate that oral ingestion of some
amino acid mixtures in combination with carbohydrates can pro-
duce strong insulinotropic effects. Four free amino acids
(leucine, phenylalanine, arginine, and glutamine) were tested.
Several in vitro studies showed that these amino acids have a
strong stimulating effect on insulin release by pancreatic b-cells
(12–14, 19). Floyd et al (5, 7) observed that 30 g arginine
injected intravenously in vivo in human subjects led to an equal
insulin response as occurred with the mixture of 10 amino acids
(30 g in total; arginine, lysine, phenylalanine, leucine, valine,
methionine, histidine, isoleucine, threonine, and tryptophan).
The data in this study show clearly that oral ingestion of large
amounts of free arginine (0.4 g arginine · kg body wt21 · h21, as
ingested in trial 2) is not an effective means of increasing plasma
insulin concentrations (Figure 4A) and plasma arginine concen-
trations (Table 3). Ingestion of drink 2 caused severe diarrhea
and the urge to defecate in all subjects for several hours during
and after the trial. These gastrointestinal problems appeared to
prevent intestinal absorption of the arginine because lower con-
centrations of arginine were seen in plasma after ingestion of
drink 2 than after ingestion of drinks 3, 4, and 10 (ingestion rates
of 0.13, 0.10, and 0.07 g arginine · kg body wt21 · h21, respec-
tively). These problems also indicate that in sports practice,
ingestion of large amounts of arginine to stimulate growth hor-
mone release and muscle anabolism is not recommended. On the
other hand, low doses of arginine (< 2 g), as present in commer-
cial sports supplements, do not increase plasma insulin and
growth hormone concentrations (23–25).
In later studies, Floyd et al (8, 9) investigated the combined
effect of intravenous administration of glucose with combina-
tions of amino acids and found that arginine-leucine and argi-
nine-phenylalanine resulted in the strongest increase in plasma
insulin concentrations. We investigated the insulinotropic effect
of oral administration of a mixture of arginine, leucine, and
phenylalanine (drink 3). A significantly greater insulin response
was seen compared with the control trial (101% greater: P < 0.05).
The increased plasma insulin concentration was attended by a
strong significant increase in plasma arginine, leucine, and
phenylalanine concentrations (Tables 3 and 6).
Sener and Malaisse (16) observed that the addition of leucine to
the incubation medium stimulates insulin release by pancreatic
b-cells in vitro. The mechanism behind this effect was investi-
gated, and it was found that leucine activates glutamate dehydro-
genase activity in pancreatic b-cells. This subsequently leads to an
increase in tricarboxylic acid cycle activity and oxygen consump-
tion of the pancreatic b-cells and is attended by increased insulin
production. The addition of glutamine to the incubation medium
potentiates the leucine-induced increase in insulin release by pro-
viding substrate for glutamate dehydrogenase, whereas glutamine
per se has no effect (16). Consequently, we studied the effect of
the addition of glutamine to drink 4. However, we observed no dif-
ferences in insulin response between trials 3 and 4, suggesting that
in humans in vivo, enough glutamine is present (600–800 mmol·L21
in plasma; Table 3) to serve as fuel for the pancreas. Also note
that the addition of free glutamine hardly influenced plasma glu-
tamine concentrations. Plasma glutamine responses after the
ingestion of drink 4 were in fact not significantly different than
after ingestion of most other drinks (drinks 3, 5–7, 9, and 10;
Tables 4 and 5). No significant differences were found between
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TABLE 7
Statistical analysis of questionnaire results1
Test drink no.
Question 1 2 3 4 5 6 7 8 9 10
1 (nausea) — — — — — — — — — —
2 (bloated feeling) 4 — — — 4 — 4 6 — 4
3 (belching) 3 3 — — 3 — 3 3,4 — 3
4 (gastrointestinal cramps) — — — — — — — — — —
5 (vomiting) — — — — — — — — — —
6 (diarrhea) 2 — 2 2 2 2 2 2 2 2
7 (urge to defecate) 2 — 2 2 2 2 2 2 2 2
8 (urge to urinate) — — — — — — — — — —
9 (headache) 4 — — — — 4 4 4 4 4
10 (dizziness) — — — — — — — — — —
1 The numbers within the table represent the drinks with a significantly (P < 0.05) higher score for the indicated symptom compared with the drink indi-
cated in the column head.
the insulin responses in test trials 5, 6, and 7 and the carbohy-
drate-only trial. Nonetheless, mean insulin responses were 55%,
25%, and 81% greater, respectively, than those observed in the
control trial. There were no differences in plasma leucine and
phenylalanine responses between the different protein hydro-
lysates tested (Tables 4 and 6). None of the hydrolysates was
associated with gastrointestinal or other complaints.
To compare the insulinotropic effect of the ingestion of the
protein hydrolysates with that of an intact protein, sodium-casein
was provided in drink 8. This resulted in an insulin response that
was not significantly different from that found with the control
trial (30% greater) and tended to be less than the responses
observed after ingestion of the protein hydrolysates (drink 5
and 7). After ingestion of the intact protein, plasma amino acid
responses over this 2-h period were in general lower than the
responses observed after ingestion of the protein hydrolysates
(Table 6). We conclude that the use of protein hydrolysates is
preferred to stimulate insulin secretion because this results in a
faster increase in plasma amino acid concentrations during a 2-h
period than does intact protein. Another practical disadvantage
of the use of an intact protein when ingested as a drink is that
most intact proteins have poor solubility in water.
On the basis of the results obtained after trials 1–8, it was con-
cluded that ingestion of free glutamine is not required to obtain an
optimal insulin response, whereas the use of free arginine should
be restricted to low doses. It was further concluded that ingestion
of relative large quantities of amino acids (arginine, leucine,
phenylalanine, and glutamine) can cause gastrointestinal and other
complaints (drinks 2, 3, and 4; Table 7). In an attempt to combine
gastrointestinal tolerance and palatability with a maximal insulin
response, drinks 9 and 10 were prepared. Ingestion of both drinks
resulted in large insulin responses. In trial 9, leucine and pheny-
lalanine were ingested in combination with the wheat protein
hydrolysate and we observed a larger insulin response (103%
greater, P < 0.05) than with the carbohydrate-only trial that was
similar to the response found in trial 3 but without the occurrence
of any gastrointestinal and other complaints. Plasma leucine and
phenylalanine responses were higher than with the control, argi-
nine, and protein (hydrolysate) drinks but were lower than the
response after the ingestion of drink 3. In trial 10, free arginine
was added to this mixture, but this showed no further increase in
insulin response (69% greater than with the control trial).
Regression analysis of the insulin responses and the changes
in plasma amino acid concentrations over the 2-h period showed
a strong positive correlation between the observed insulin
response and changes in plasma leucine (P < 0.003), phenylala-
nine (P < 0.02), and tyrosine (P < 0.0001) concentrations. This
agrees with several in vitro studies in which b-cells of the pan-
creas were incubated with leucine and phenylalanine (11–20)
and with the in vivo studies by Floyd et al (5–10) in which
amino acids were infused. The correlation observed with tyro-
sine concentrations may be explained by the fact that tyrosine is
formed by the hydroxylation of phenylalanine when large
amounts of phenylalanine are ingested (26). As such, tyrosine
concentrations were higher in drinks containing large amounts
of phenylalanine (Tables 3–5). In addition, we observed an
unexplained positive correlation with citrulline (P < 0.002) and
a negative correlation with glutamate (P < 0.019).
The main conclusion is that oral intake of amino acids in com-
bination with carbohydrates can result in an insulinotropic effect
as much as 100% greater than with the intake of carbohydrates
only. It was shown that a mixture of free leucine, phenylalanine,
and arginine can produce a large insulinotropic effect when
ingested in combination with carbohydrates. It was also shown
that the addition of leucine and phenylalanine to a (wheat) protein
hydrolysate can create a similar insulinotropic effect without any
gastrointestinal discomfort. These mixtures should provide a use-
ful tool to strongly elevate plasma insulin concentrations in future
metabolic studies in healthy subjects and in patients.
We acknowledge the support of Kees Verbeek, who performed the plasma
amino acid measurements.
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